“…BACKGROUND: The Montgomery case in 2015 resulted in a pivotal change in practice, leading to a patient-centric approach for informed consent. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The primary outcome is change in Montgomery–Åsberg Depression Scale (MADRS) score over time and across groups. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Depressive psychopathology was assessed using Beck's Depression Inventory (BDI), Montgomery-Asberg Depression Rating Scale (MADRS) and Structured Clinical Interviews for Diagnostic and Statistical Manual of Mental Disorders (SCID) for DSM-IV. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The Sexual Compulsivity Scale and the Hypersexual Disorder: Current Assessment Scale were used for assessing hypersexual behavior, the Montgomery-Åsberg Depression Scale-self rating was used for depression severity, and the Childhood Trauma Questionnaire (CTQ) was used for assessing history of childhood adversity. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Non-responders (< 50% improvement in Montgomery-Åsberg Depression Rating Scale [MADRS] scores) crossover to receive the alternate treatment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In addition, a mixed model analysis was applied to compare the weekly Montgomery-Åsberg Depression Rating Scale (MADRS) scores with Mood 24/7 scores over an average of 3 months. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Outcomes were remission rate (primary), response rate, improvement on the Montgomery‐Åsberg Depression Rating Scale and 17‐item Hamilton Depression Rating Scale scores, discontinuation rate, and incidence of individual adverse events. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Efficacy was measured using the Montgomery–Åsberg Depression Rating Scale (MADRS). FORWARD-5 achieved the primary endpoint and demonstrated that adjunctive BUP/SAM 2 mg/2 mg was superior to placebo (average difference change from baseline to week 3 through end of treatment [EOT] in MADRS-6 and −10 versus placebo: −1.5, P = 0.018; −1.9, P = 0.026, respectively). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We also validated our framework on the publicly available Shenzhen and Montgomery lung datasets and compared its performance to the currently available solutions. …”
Enlace del recurso
Enlace del recurso

“…Clinically relevant improvements were achieved with discontinuation of trimetazidine according to changes in scores of each part of the Movement Disorder Society-sponsored Unified Parkinson’s Disease Rating Scale (Part I: −25.7%, p < 0.001; Part II: −23.8%, p < 0.001; Part III: −28.5%, p < 0.001; Part IV: −30.1%, p = 0.004) and total scores of the Non-Motor Symptoms Scale (−25.6%, p = 0.004) and the Montgomery-Asberg-Depression Rating Scale (−20.1%, p = 0.001). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Efficacy parameters were changes in the Montgomery‐Åsberg Depression Rating Scale (MADRS) total scores (primary) and Clinical Global Impressions — Severity (CGI‐S) scores (secondary) from baseline to Week 6 compared to placebo. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The primary end point was the change from baseline in the Montgomery-Åsberg Depression Rating Scale (MADRS) score at 24 h after the last infusion. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Participants with BD-I/-II currently experiencing a major depressive episode will be randomized to one of two conditions (n = 20/group): 1) inhaled N(2)O plus intravenous saline, or 2) inhaled room air plus intravenous midazolam. Montgomery-Asberg Depression Rating Scale scores will serve as the primary endpoint. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Adults meeting the DSM-5 criteria for MDD with at least moderate depressive symptom severity [i.e., Montgomery Åsberg Depression Rating Scale (MADRS) total score ≥ 20] were treated with open-label vortioxetine (10–20 mg/day, flexibly-dosed) for 8 weeks. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The primary outcome is in the Montgomery–Asberg depression rating scale. The secondary outcomes are the quick inventory of depressive symptomatology—self report, Hamilton anxiety rating scale, young mania rating scale, cognitive function, inflammatory factors, and intestinal flora. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The outcome was measured with the Eating Disorder Examination Questionnaire (EDE-Q) and the Montgomery Åsberg Depression Rating Scale (MADRS-S). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Rater-based questionnaires, such as the Positive and Negative Syndrome Scale (PANSS), Montgomery Asberg Depression Rating Scale (MADRS), and Psychotic Symptom Rating Scales-Auditory Hallucination (PSYRATS-AH) were administered at baseline to collect clinical outcomes. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Sandy siliciclastic deposits of the Ediacaran Wood Canyon Formation (WCF) in the Montgomery Mountains, Nevada, contain two fossil morphologies with similar shapes and sizes: one exhibits mm-scale ridges and a distinct lower boundary and the other is devoid of these diagnostic features. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We propose a Computer-Aided Detection model using Deep Convolutional Neural Networks to automatically detect TB from Montgomery County (MC) Tuberculosis radiographs. Our proposed model performed at 87.1% validation accuracy and evaluated using confusion matrix and accuracy as metrics.…”
Enlace del recurso
Enlace del recurso

“…Depression symptoms were assessed at baseline, 24 h, and 7 days after treatment with Montgomery-Åsberg Depression Rating Scale (MADRS) and Beck Depression Inventory (BDI-II). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso